Abstract
Atherosclerosis is a systemic disease, and its development is dependent upon a complex interplay among numerous genetic, epigenetic, and environmental risk factors. It is increasingly recognized that ambient UFP exposure promotes vascular oxidative stress and inflammatory responses. In this study, we tested the hypothesis that UFP attenuates eNOS activity via S‐glutathionylaiton. Treatment of human aortic endothelial cells (HAEC) with ambient UFP (Dp<100nm) significantly inhibited nitric oxide (NO) production as measured by Griess assay (Control: 3.645, UFP: 1.662, P<.01, n=4). To assess whether oxidative stress induced eNOS uncoupling via S‐glutathionylation, we demonstrated that UFP treatment increased eNOS S‐glutathionylation in HAEC by a modified ELISA procedure. To inhibit S‐glutahionylation, we over‐expressed glutaredoxin‐1 (Grx‐1), and showed a significant attenuation of UFP‐mediated decrease in NO production (LacZ+UFP: .338, Grx1+UFP: .630, P<.01, n=6). Thus, our findings suggest that UFP inhibited eNOS activity via an increase in S‐ glutathionylation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.